Action funded by the AVI (Valencian Innovation Agency).
We are proud to announce that the project REPOSITIONING A DRUG FOR SPINAL MUSCULAR ATROPHY (TREAT-AME) has been selected as an Action funded by the AVI (Valencian Innovation Agency).
The three-year project involves different valorization objectives and includes clinical testing of the candidate drug, which could lead to the creation of a spin-off company for its commercialization. The project reinforces the focus and experience of the Translational Genomics laboratory in high-profile research and in translating the results to patients and society in general.
Images:
